Increased expression of alpha-1-antitrypsin, glutathione S-transferase π and vascular endothelial growth factor in human pancreatic adenocarcinoma

American Journal of Surgery

Volumn 184, Issue 6, 2002, Pages 642-647

  Trachte, Aaron L ^a,b   Suthers, Sara E ^a,b   Lerner, Megan R ^a,b   Hanas, Jay S ^a   Jupe, Eldon R ^a,c   Sienko, Anna E ^d   Adesina, Adekunle M ^d   Lightfoot, Stan A ^d   Brackett, Daniel J ^a,b   Postier, Russell G ^a,b   Mercer, David ^e   Barnes, Steve ^e   Lang, Nick ^e   Moore, Ernest ^e  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e NONE

Author keywords

Alpha 1 antitrypsin; cDNA array; Glutathione S transferase ; Pancreatic adenocarcinoma; Vascular endothelial growth factor

Indexed keywords

ALPHA 1 ANTITRYPSIN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; VASCULOTROPIN;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC SELECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 0036911018     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01105-4     Document Type: Conference Paper

References (25)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15-36.
2. Yeo C., Cameron J. Prognostic factors in ductal pancreatic cancer. Langenbeck's Arch Surg. 383:1998;129-133.
3. Sohn T.A., Yeo C.J. The molecular genetics of pancreatic ductal carcinoma a review . Surg Oncol. 9:2000;95-101.
4. Kleef J.K., Friess H., Berberat P.O., et al. Pancreatic cancer - new aspects of molecular biology research. Swiss Surg. 6:2000;231-234.
5. Hruban R.H., Offerhaus G.J.A., Kern S.E., et al. Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg. 5:1998;383-391.
6. Zhou W., Sokoll L.J., Bruzek D.J., et al. Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev. 7:1998;109-112.
7. Goggins M., Shekher M., Turnacioglu K., et al. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 58:1998;5329-5332.
8. Rozenblum E., Schutte M., Goggins M., et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57:1997;1731-1734.
9. Khan J., Saal L.H., Bittner M.L., et al. Expression profiling in cancer using cDNA microarrays. Electrophoresis. 20:1999;223-229.
10. Travis J., Salvesen G. Human plasma proteinase inhibitors. Ann Rev Biochem. 52:1983;655-709.
11. Freeman H.J., Weinstein W.M., Schnitka T.K., et al. Alpha-1-antitrypsin deficiency and pancreatic fibrosis. Ann Intern Med. 85:1976;73-76.
12. Tanno S., Obara T., Fujii T., et al. alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation. Int J Pancreatol. 26:1999;43-47.
13. Dickson I., Alper C. Changes in serum proteinase inhibitor levels following bone surgery. Clinica Chimica Acta. 54:1974;381-385.
14. Banda M.J., Rice A.G., Griffin G.L., Senior R.M. The inhibitory complex of human α1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med. 167:1988;1608-1615.
15. Troll W., Klassen A., Janoff A. Tumorigenesis in mouse skin inhibition by synthetic inhibitors of proteases . Science. 169:1970;1211-1213.
16. Dabbagh K., Laurent G.J., Shock A. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol. 186:2001;73-81.
17. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family regulation of GST and contribution of the isoenzymes to cancer chemoprevention and drug resistance . Crit Rev Biochem Mol Biol. 30:1995;445-600.
18. DeBruin W.C.C., Wagenmans M.J.M., Peters W.H.M. Expression of glutathion S-transferase α, P1-1 and T1-1 in the human gastrointestinal tract. Jpn J Cancer Res. 91:2000;310-316.
19. Nitsu Y., Takahashi Y., Tadanori S., et al. Serum glutathione S-transferase π as a tumor marker for gastrointestinal malignancies. Cancer. 63:1989;317-323.
20. Viekkola T., Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 9:1999;211-220.
21. Furutani M., Arii S., Mizumoto M. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett. 122:1998;209-214.
22. Sato H., Okada Y., Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thrombos Hemostas. 78:1997;497-500.
23. Papadopoulos N., Lindblom A. Molecular basis of HNPCC mutations of MMR genes . Hum Mutat. 10:1997;89-99.
24. Efthimiou E., Crnogorac-Jurcevic T., Lemoine N.R., Brentnall T.A. Inherited predisposition to pancreatic cancer. Gut. 48:2001;143-147.
25. Batra S.K., Metzgar R.S., Hollingsworth M.A. Molecular cloning and sequence analysis of the human ribosomal protein S16. J Biol Chem. 266:1991;6830-6833.